WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the 2011 NewsMakers in the Biotech Industry Conference at the Millennium Broadway Hotel and Conference Center in New York City on Friday, October 21, 2011 at 2:00 p.m. Eastern Time.
